Jinxin Fertility Group Limited (abbreviated as JXR) disclosed that it repurchased 1.31 million ordinary shares on 23 September 2026 through the Hong Kong Stock Exchange. The shares were bought at prices ranging from HKD 2.13 to HKD 2.16, for a volume-weighted average cost of HKD 2.14 per share, bringing the cash outlay to HKD 2.80 million.
Following the transaction, the number of issued shares excluding treasury stock fell to 2.67 billion, representing a 0.05 % reduction from the previous day. Treasury shares rose to 30.48 million, while the total issued share count remained unchanged at 2.71 billion.
Since shareholders approved the current repurchase mandate on 25 June 2026, JXR has repurchased 43.02 million shares, equivalent to 1.64 % of the company’s issued share capital on the mandate date. The repurchases utilise roughly 16.40 % of the 262.51 million shares authorised under the mandate.
In addition to treasury stock, 92.47 million shares bought between 27 March and 25 August 2026 are awaiting cancellation, equal to about 3.42 % of the current issued share base.
Under Hong Kong Listing Rules, JXR is restricted from issuing new shares or disposing of treasury shares until 23 October 2026, 30 days after the latest on-market buy-back.
Comments